Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions
Open accessAbstract
OBJECTIVE: The aim of this study was to differentiate benign from malignant adrenal tumors using positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) in patients with unilateral adrenal masses originally detected by CT or MR imaging. CONCLUSION: PET imaging with FDG can metabolically characterize adrenal masses. Abnormally increased FDG uptake in adrenal malignancies allows one to differentiate these abnormalities from benign lesions. Whole-body PET can also reveal extraadrenal tumor sites in patients with malignant tumors, using a single imaging technique for accurate disease staging.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Benign adrenal lesions, particularly functional adenomas and nonmetastatic pheochromocytomas, can be FDG positive.
“One limitation is that benign adrenal lesions particularly functional adenomas and nonmetastatic pheochromocytomas can be FDG positive (313,314).”
From Adrenal incidentaloma (2020) · cites this paper as [313]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 11 · Cited by 159
Research works printed but not linked: 1
- Gross MD, Shapiro B. Clinical review 50: clini-
- Authors
- Maurea, S., Mainolfi, C., Bazzicalupo, L., Panico, M. R., Imparato, C., Alfano, B., Ziviello, M., & Salvatore, M.
- Affiliations
- University of Naples Federico II (IT)
- Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Venue
- American Journal of Roentgenology
- Publisher
- American Roentgen Ray Society
- Published
- 1999-07
- Volume
- 173
- Issue
- 1
- Pages
- 25-29
- ISSN
- 0002-9580 (ISSN-L)
- 0361-803X
- 1546-3141
- OpenAlex
- W2145251853
- Cited by
- 159
- References
- 11
- Citations by year
- 2024: 1 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 7
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Roentgenology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Consiglio Nazionale delle Ricerche
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Epidemiology › Neuroendocrine Tumor Research Advances
- Keywords
- adrenal tumors, adrenal mass, FDG-PET, 18F-fluorodeoxyglucose, benign versus malignant differentiation, cancer metabolism, disease staging, adrenal cancer
- MeSH terms
- Adolescent, Adrenal Gland Neoplasms, Adult, Aged, Diagnosis, Differential, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Tomography, Emission-Computed, Tomography, X-Ray Computed, Radiopharmaceuticals, Fluorodeoxyglucose F18
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
